768 related articles for article (PubMed ID: 30558587)
21. Molecular identification of sulfadoxine-pyrimethamine resistance in malaria infected women who received intermittent preventive treatment in the Democratic Republic of Congo.
Ruh E; Bateko JP; Imir T; Taylan-Ozkan A
Malar J; 2018 Jan; 17(1):17. PubMed ID: 29316929
[TBL] [Abstract][Full Text] [Related]
22. Molecular markers associated with resistance to commonly used antimalarial drugs among Plasmodium falciparum isolates from a malaria-endemic area in Taiz governorate-Yemen during the transmission season.
Alareqi LMQ; Mahdy MAK; Lau YL; Fong MY; Abdul-Ghani R; Mahmud R
Acta Trop; 2016 Oct; 162():174-179. PubMed ID: 27343362
[TBL] [Abstract][Full Text] [Related]
23. Stable high frequencies of sulfadoxine-pyrimethamine resistance associated mutations and absence of K13 mutations in Plasmodium falciparum 3 and 4 years after the introduction of artesunate plus sulfadoxine-pyrimethamine in Ujjain, Madhya Pradesh, India.
Pathak A; Mårtensson A; Gawariker S; Sharma A; Diwan V; Purohit M; Ursing J
Malar J; 2020 Aug; 19(1):290. PubMed ID: 32795288
[TBL] [Abstract][Full Text] [Related]
24. Molecular markers of resistance to amodiaquine plus sulfadoxine-pyrimethamine in an area with seasonal malaria chemoprevention in south central Niger.
Grais RF; Laminou IM; Woi-Messe L; Makarimi R; Bouriema SH; Langendorf C; Amambua-Ngwa A; D'Alessandro U; Guérin PJ; Fandeur T; Sibley CH
Malar J; 2018 Feb; 17(1):98. PubMed ID: 29486766
[TBL] [Abstract][Full Text] [Related]
25. Polymorphisms in pfdhfr and pfdhps genes after five years of artemisinin combination therapy (ACT) implementation from urban Kolkata, India.
Chatterjee M; Ganguly S; Saha P; Guha SK; Maji AK
Infect Genet Evol; 2017 Sep; 53():155-159. PubMed ID: 28533179
[TBL] [Abstract][Full Text] [Related]
26. Persistence of Sulfadoxine-Pyrimethamine Resistance Despite Reduction of Drug Pressure in Malawi.
Artimovich E; Schneider K; Taylor TE; Kublin JG; Dzinjalamala FK; Escalante AA; Plowe CV; Laufer MK; Takala-Harrison S
J Infect Dis; 2015 Sep; 212(5):694-701. PubMed ID: 25672905
[TBL] [Abstract][Full Text] [Related]
27. High prevalence of pfdhfr-pfdhps triple mutations associated with anti-malarial drugs resistance in Plasmodium falciparum isolates seven years after the adoption of sulfadoxine-pyrimethamine in combination with artesunate as first-line treatment in Iran.
Rouhani M; Zakeri S; Pirahmadi S; Raeisi A; Djadid ND
Infect Genet Evol; 2015 Apr; 31():183-9. PubMed ID: 25653131
[TBL] [Abstract][Full Text] [Related]
28. Therapeutic efficacy of sulfadoxine-pyrimethamine and prevalence of resistance markers in Tanzania prior to revision of malaria treatment policy: Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase mutations in monitoring in vivo resistance.
Mugittu K; Ndejembi M; Malisa A; Lemnge M; Premji Z; Mwita A; Nkya W; Kataraihya J; Abdulla S; Beck HP; Mshinda H
Am J Trop Med Hyg; 2004 Dec; 71(6):696-702. PubMed ID: 15642957
[TBL] [Abstract][Full Text] [Related]
29. High prevalence of sulphadoxine-pyrimethamine resistance-associated mutations in Plasmodium falciparum field isolates from pregnant women in Brazzaville, Republic of Congo.
Koukouikila-Koussounda F; Bakoua D; Fesser A; Nkombo M; Vouvoungui C; Ntoumi F
Infect Genet Evol; 2015 Jul; 33():32-6. PubMed ID: 25934142
[TBL] [Abstract][Full Text] [Related]
30. Molecular Evidence for
Wedam J; Tacoli C; Gai PP; Siegert K; Kulkarni SS; Rasalkar R; Boloor A; Jain A; Mahabala C; Baliga S; Shenoy D; Devi R; Gai P; Mockenhaupt FP
Am J Trop Med Hyg; 2018 Dec; 99(6):1508-1510. PubMed ID: 30398146
[TBL] [Abstract][Full Text] [Related]
31. Occurrence of septuple and elevated Pfdhfr-Pfdhps quintuple mutations in a general population threatens the use of sulfadoxine-pyrimethamine for malaria prevention during pregnancy in eastern-coast of Tanzania.
Bwire GM; Mikomangwa WP; Kilonzi M
BMC Infect Dis; 2020 Jul; 20(1):530. PubMed ID: 32698764
[TBL] [Abstract][Full Text] [Related]
32. Molecular surveillance of anti-malarial drug resistance genes in Plasmodium falciparum isolates in Odisha, India.
Rana R; Khan N; Sandeepta S; Pati S; Das A; Bal M; Ranjit M
Malar J; 2022 Dec; 21(1):394. PubMed ID: 36566182
[TBL] [Abstract][Full Text] [Related]
33. Comparative efficacies of artemisinin combination therapies in Plasmodium falciparum malaria and polymorphism of pfATPase6, pfcrt, pfdhfr, and pfdhps genes in tea gardens of Jalpaiguri District, India.
Saha P; Guha SK; Das S; Mullick S; Ganguly S; Biswas A; Bera DK; Chattopadhyay G; Das M; Kundu PK; Ray K; Maji AK
Antimicrob Agents Chemother; 2012 May; 56(5):2511-7. PubMed ID: 22314538
[TBL] [Abstract][Full Text] [Related]
34. Molecular monitoring of Plasmodium falciparum resistance to antimalarial drugs after adoption of sulfadoxine-pyrimethamine plus artesunate as the first line treatment in Iran.
Afsharpad M; Zakeri S; Pirahmadi S; Djadid ND
Acta Trop; 2012 Jan; 121(1):13-8. PubMed ID: 22001304
[TBL] [Abstract][Full Text] [Related]
35. The prevalence and antifolate drug resistance profiles of Plasmodium falciparum in study participants randomized to discontinue or continue cotrimoxazole prophylaxis.
Juma DW; Muiruri P; Yuhas K; John-Stewart G; Ottichilo R; Waitumbi J; Singa B; Polyak C; Kamau E
PLoS Negl Trop Dis; 2019 Mar; 13(3):e0007223. PubMed ID: 30897090
[TBL] [Abstract][Full Text] [Related]
36. Changes in the frequencies of Plasmodium falciparum dhps and dhfr drug-resistant mutations in children from Western Kenya from 2005 to 2018: the rise of Pfdhps S436H.
Pacheco MA; Schneider KA; Cheng Q; Munde EO; Ndege C; Onyango C; Raballah E; Anyona SB; Ouma C; Perkins DJ; Escalante AA
Malar J; 2020 Oct; 19(1):378. PubMed ID: 33092587
[TBL] [Abstract][Full Text] [Related]
37. Molecular characterization of Plasmodium falciparum antifolate resistance markers in Thailand between 2008 and 2016.
Sugaram R; Suwannasin K; Kunasol C; Mathema VB; Day NPJ; Sudathip P; Prempree P; Dondorp AM; Imwong M
Malar J; 2020 Mar; 19(1):107. PubMed ID: 32127009
[TBL] [Abstract][Full Text] [Related]
38. Clinical and molecular monitoring of Plasmodium falciparum resistance to antimalarial drug (artesunate+sulphadoxine-pyrimethamine) in two highly malarious district of Madhya Pradesh, Central India from 2012-2014.
Mishra S; Bharti PK; Shukla MM; Ali NA; Kashyotia SS; Kumar A; Dhariwal AC; Singh N
Pathog Glob Health; 2017 Jun; 111(4):186-194. PubMed ID: 28549390
[TBL] [Abstract][Full Text] [Related]
39. Prevalence of Plasmodium falciparum parasites resistant to sulfadoxine/pyrimethamine in the Democratic Republic of the Congo: emergence of highly resistant pfdhfr/pfdhps alleles.
Nkoli Mandoko P; Rouvier F; Matendo Kakina L; Moke Mbongi D; Latour C; Losimba Likwela J; Ngoyi Mumba D; Bi Shamamba SK; Tamfum Muyembe JJ; Muepu Tshilolo L; Parzy D; Sinou V
J Antimicrob Chemother; 2018 Oct; 73(10):2704-2715. PubMed ID: 30053021
[TBL] [Abstract][Full Text] [Related]
40. Molecular monitoring of Plasmodium falciparum super-resistance to sulfadoxine-pyrimethamine in Tanzania.
Kavishe RA; Kaaya RD; Nag S; Krogsgaard C; Notland JG; Kavishe AA; Ishengoma D; Roper C; Alifrangis M
Malar J; 2016 Jun; 15():335. PubMed ID: 27339129
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
